<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 317 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page316.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=317">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 317 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 317</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=317"><img src="../thumb/317.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>280 / 2020-04                                                            Anti-Microbials - 18.12
   Indications: In combinat.with other antiretrovir.in adults with   (S4) TABS, 49/20.2.8/0097  palpitat., tachycard., asthma, sinusit., dyspn., URTI, gastrit., gastroen-
   HIV-1 infect.                722296-001: 30, R944,09       terit., gastro-oesophag. reflux, constip., malabsorpt., hepatit., hepat.
   (S4) TABS, 45/20.2.8/0112    Dosage: Init. ther.by physic.exper.in HIV infect.managem. Adults   enzyme incr., hepat.fail., acne, alopec/, eczema, folliculit., seborrh.,
   717981-001: 30, R456,37      & adolesc.weigh. &gt; 40 kg: 1 tab. once dly. Separ.dolutegravir/   skin exfoliat., urticar., erythema multiforme, nail disords., skin discol-
   Dosage: Ther.init.by dr.exper.in HIV managem. Adults: 1 tab.once   abacavir/ lamuvidine preps.to be admin.in cases where discont./  our., Stev.-Johns.syndr., arthralg., myalg., myopathy., alcohol intol.,
   dly.with food. Separ. emtricitab./ tenofovir preps.avail.if discont.of   dos.adjustm.reqd.  allerg.reacts., asthen., hot flush., influenza-like sympts., malaise,
   one of compon.of combinat. indic.  Contraindications: Pts.und.18 yrs., mod.to sev.liv funct.impairm.,   pain, syncope, redistrib./accumulat. of body fat.
   Contraindications: Insuff.data avail.on expos. pregn., lactat.,   concom. dofetilide/pilsicainide/ metformin/ meds.cont.any of same   Warnings and special precautions: Lactic. acidos.& sev.he-
   safety & effic.not est.in childr.& adolesc. und.18 yrs./signif.underly.  act.compon., safety in pregn.not est., lactat., ren.impairm.with   patomegaly with steatos. incl.fatal., obesity & prolong.nucleo-
   liv.disords/ hepatit. B vir.& HIV co-infects., dos.recomm.for elderly   creatin.clear.of &lt;50 mg/min., dolutegrav.co-admin. with polyval.  side use poss. risk fact.for lact.acidos., pts.with liv.dis.risk fact.,
   over 65 yrs., mod.to sev.ren.impairm. (creat. clear.of &lt; 50 ml/min./  cation-cont. antacids.  suspend. treatm.if clinic./lab.find. suggest.lact. acidos./ hepato-
   haemodyalis.), chron. HBV infect., concom.drugs cont.emtricit-  Side effects: Fatal hypersens.reacts.pres.like a flu-like illn./gastro-  toxic., test for chron.hepatit.B bef. init.ther., not indic.for treatm.
   abine/ tenovofir disoxopril (as fumarate)/other cytidine analog.   enterit./rash, dyspn., cough, fev., fatig., malaise, elev.LFT, myalg., ren.   of chron. HBV infect., safety & effic.not est.in hepatit. B vir.co-
   eg.lamivudine/zalcitabine, rare heridit. galact.intol.probl./ Lapp lact.  & urin disords., headache, mytochondr.dysfunct., pancreatit., organ   infects., monit. hepat.funct.for sev.mnths.in pts.co-infect. with
   defic./gluc-galact. malabsorpt., concom.didanosine.  dysfunct.incl.liv.inj., GI disturbs., lact. acidos./sev.hepatomegaly with   HIV & HBV who discont.ther.& appropr.init.of anti-hepatit. B ther.
   Side effects: Ren.impairm.incl.ac.ren.fail. & Fanconi syndr., bone   steatos.incl fatal.cases esp.women, CNS/psych.effs., osteonecros.,   poss.necess., determ.creatin. clear. bef.init.ther., ren.funct.monit.
   miner.densit.decr. if hip & spine/ bone fract., lactic.acidos.& sev.   hypertriglyceridaem., hyperglycaem., bld. dyscras., dizzin., hepatit.,   in pts.at risk/ hist. of ren.dysfunct., avoid with concom./rec. ne-
   hepatomegaly with steatos.incl.fatal., lipodystrophy, neutropen.,   hyperlactataem., arthralg., musc.disords., rhabdomyolys., paraes-  phrotox. agents, pregn.test for women of child-bear. potent.bef.
   allerg.reacts., hypophosphataem., hypertriglyceridaem., hypergly-  thes., periph.neuropathy, skin reacts. incl. erythema multiforme/  init.ther., barr.contracept.tog.with other methods recomm., elderly,
   caem., hypercholesterolaem., insul. resist., hyperlactataem., psych.  Stev.-Johns.syndr.& tox. epiderm. necrolys., body fat redistribut./   concom. lamivudine/ meds.contain.lamivudine in combinat. due
   disords., dizzin., headache, dyspn., GI disturbs., rais.liv.enzym., pan-  accumulat./ periph.& fac.wast./breast enlargem.  to similarit.betw.emtricitabine & lamivudine, monit.BMD in pts.
   creatit., hyperbilirubinaem., hepatit., skin disords.incl. vesiculobull.  Warnings and special precautions: Cross. placenta/ teratogen.  with patholog.bone fract. hist./ at risk of osteopen., Ca & vit.D
   rash, incr.pigmentat., myopathy, osteomalac., proteinur., ac.tubul.   in animals, lamivudine excret. in breast milk, limit. data in elderly   supplementat.poss benefic., redistribute./accumulate.of body
   necros., nephrit., nephrogen.diab.insipid., pain, asthen.  &gt; 65 yrs., screen. recomm.for carriage of HLA-B*5701 allele in pts.  fat, immune reconstit.syndr., discont.ther.with sev.skin rash as-
   Special precautions: Not be used in pregn. unless no altern.avail.,   without prior abacavir expos., hypersens. reacts.to abacavir char-  soc.with blister./ desquamat./mucos. involvem. & fev., treatm.
   effect.contracept.with concom.use, excret.in milk of rats, elderly   act.by multi-organ/body syst. involvem.have proven fatal, no re-  discont.poss.reqd.if ser. psych. sympt.exper., monit.liv.enzym.in
   esp. with ren.insuff., ren.funct.monit.recomm.bef.init. ther., avoid   challeng. aft. abacavir hypersens.reacts.which are are more sev.   mild to mod. liv.dis & chron.hepatit.B or C, eval.risk vs. benef.of
   combin.with concurr./recent nephrotox. meds., avoid in antiretrov.  on re-challeng.incl.life-threat.hypotens.& death within hrs., discont.  cont.ther.if ser.transaminase. lev.persist. 5x&gt;ULN, opportunist.in-
   exper.pts. with HIV-1 harbour.K65R mutat., bone monit.in pts. with   ther.immed.if any hypersens. react.susp./occurs.& init.appropr.ther.,   fects & other HIV complicat. still poss., ther.not proven to prev.HIV
   patholog.bone fract.hist./osteopen.risk, hepatit. exacerbat.poss.aft.  joint pain/stiffn./movem.diffic., discont.ther.until pancreatit. exclud.  transmiss. through sex.cont./bld.contam., contin.approp. precaut.
   ther.discont., monit. hepat. funct.for sev.mnths.if discont.& pts.co-  in cases of N&V/abdom.pain/ elev. biochem.mark., suspend ther.in   prevent.HIV transmiss.risk, monit. cholester. & triglyceride levels,
   infect. with HIV & HBV, pt.monit.in case of pre-exist. liv.dysfunct.,   cases of clinic. feat./ laborat.find.poss.indic.lact.acidos. developm.   seiz.hist., addit. 200 mg/day of efavirenz recomm.when TRENVIR
   cons.ther.interr./discont.if evid. of worsen.liv.dis., obese women with   with/without hepatit., pts.with known risk for liv.dis., lipodystrophy   is co-admin.with rifampicin, dly.dos of rifabutin should be incr.by
   hepatomegaly/ hepatit/other known liv.dis./hepat. steatos. risk fact.  & metabol.abnorm., opportunist. infects.& other HIV complicat.may   50 % when admin.with TRENVIR, do not admin.concom.saquinavir
   incl.cert.meds.& alcoh., incr.risk with pts. co-infect.with hepatit.C &   still devel., ARV ther.will not prev.transmiss.through sex. cont.& bld.  as sole protease inhibit., no dos. recomm.for itraconazole avail.
   treatm.with alpha interferon & ribavirin, eval.phys.fat.distrib. signs,   transfus.& appropr.precaut.to contin., coron.heart dis.risk fact., not   theref. seek alt.antifung., rash report.with efavirenz & clarithro-
   lipid.disord.managem., meas.fast.ser. lipids/ bld.gluc., inflamm.re-  recomm.in pts. with integrase inhibit.resist., immune reconstitut.   mycin theref.consid.alt., combin.with other macrolides not stud.,
   spons.to indolent/ resid. infects. necessit.furth.eval.& treatm., poss.   syndr., eval.inflamm.sympt.& init. treatm. if necess., auto-immune   period. plasma monit.of anticonvuls.ther., monit.conc.of concom.
   mitochondr. dysfunct.in childr.expos.in utero to nucleoside/ nucleo-  disords., per.liv. funct.monit. recomm.in hepatit.B &/C co-infect. pts.,   tacrolimus for at least 2 wks.
   tide analog., immune reactiv. syndr., eval.in case of any inflamm.  init./maint.effect.HBV ther.when start. Trelavue in hepatit. B co-  Interactions: Efavirenz decr.voriconazole plasma conc.& vice versa,
   sympt., incr.risk for sev.hepat.adverse effs. in chron.hepatit.B or   infect.pts., concom. meds. chang. dolutegrav./abacavir/lamuvidine   amprenavir ser.conc decr., conc. of drugs elimin.by act.tubul.secret.
   C co-infect., avoid concom./recent use with nephrotox. agent, not   expos. or vice versa, admin.2 hrs.bef./6 hrs.aft. Ca/Fe supplem.or   may incr., plasma conc.of other compds.that are CYP3A4 substrat.
   recomm.as part of triple nucleoside regim., opportunist.infects.&   with food, admin.2 hrs.bef./ 6 hrs. aft. polyval.cation-cont.antacids,   poss.decr., atazanavir/ritonavir incr. tenofovir conc., poss.Ca chan.
   HIV complic. may cont., not prov.to prev.transmiss.risk through sex.  concom. ETR not recomm.unless receiv.concom.ATV + RTV/ LPV +   block.conc.decr., decr. carbamazepine lev., clarithromyc.plasma lev.
   cont./bld.contam., appropr.precaut.to contin., discont.ther.if sympt.  RTV or DRV + RTV, concom.efavirenz/ nevirapine/ rifampicin/tiprana-  chang., didanosine conc.incr.with multip.tenofovir dos., HMG-CoA
   of hyperlactataem./ metabol. or lact.acidos./progress.hepatomeg-  vir/ritonavir not recomm., avoid concom.oxcarbazepine/ phenytoin/   reduct.inhibit./indinavir/ itraconazole conc.decr., potent.decr.keto-
   aly/ rapid.elev. aminotransf.lev.occur.  phenobarb./ carbamazepine/St. John’s Wort, concom. methadone/  conazole conc., decr.lopinavir expos.with lopinavir/ritonavir & efa-
   Drug interactions: Ser.conc.incr.with concom. drugs elimin.by   zalcitabine, lamivudine not recomm.with concom.emtricitabine or   virenz, decr.methadone plasma conc.& poss. opiate withdr.signs
   act.tubul.secret., ser.conc.incr.by agents decr.ren.funct., atazanavir   emtricitabine-cont. fix.dos.combin.  with efavirenz, ethinyl oestrad. conc.incr., reduc./incr.plasma lev.
   & lopinavir /ritonavir incr.tenofovir conc., AUC & C min of atazanavir   Drug interactions: Poss.incr.metformin conc., reduc.dolutegravir   of phenytion/ phenobarb./other anticonvuls which are substrat. of
   decr., C max & AUC of didanosine incr.  plasma conc.with etravine/ efavirenz/nevirapine/rifampicin/tipra-  CYP450 isoenzym., rifampicin decr.efavirenz conc., rifabutin conc.
   TIVICAY, GSK [P/S]           navir/ ritonavir, incr.dolutegravir plasma conc.with atazanavir, poss.  decr., sequinavir conc.reduc., sertraline conc.decr., reduc.efavirenz
   Dolutegravir                 decr.dolutegravir conc.with oxcarbazepine/ phenytoin/phenobarb./   conc.with St John’s Wort expect., poss.incr.conc.of emtricitabine
   Indications: HIV treatm.in adults 18 yrs.& old.in combinat.awith   carbamazepine/St John’s Wort though no studies, occas. methadone   /tenofovir &/other ren.elimin.meds. with meds.reduc.ren.funct./
   other antiretrovir.ther.     re-titrat.may be reqd., lamivudine poss.inhib.intracellul.phosphorylat.  compete for act.tubul. secret., decr.expos. of tacrolimus expect.
   (S4) TABS, 48/20.2.8/0403    of zalcitabine, decr.dolutegravir conc.with tipranavir/ ritonavir, poss.  TRIBUSS, (Aspen Pharmacare) Pharmacare, [P/S]
   722009-001: 50 mg, 30, R920,91  incr.dofetilide/pilsicainide plasma conc. with dolutegravir.  Tenofovir disoproxil fumarate 300 mg, efavirenz 600 mg, emtric-
   Dosage: Admin.by med.pract.exper.in HIV treatm. Adults: Treatm.  TRENVIR, Cipla Medpro [P/S]  itabine 200 mg.
   naive & treatm.-exper.and integrase inhibit.naive: Recomm.  Emtricitabine 200 mg, tenofovir disoproxil fumarate 300 mg, efa-  Indications: Alone as complete regimen or in combinat.with other
   dos: 50 mg once dly.         virenz 600 mg.                antiretrovir.in adults with HIV-1.
   Integrase inhibit.resist.: 50 mg 2xdly.  Indications: HIV-1 infect.treatm.in adults.  (S4) TABS, 44/20.2.8/0980
   Contraindications: Concom.dofelitide/ pilsicainide/ metformin,   (S4) TABS, 44/20.2.8/0780  716630-001: 30, R466,97
   mod./sev.hepat.impairm., safety in pregn.& lactat.not est.  721430-001: 30, R240,00  Dosage: Adults: 1 tab.once dly.on empty stomach. Bedt.dos.may
   Side effects: Hypersens.reacts.incl.sev.rash/ constitutional find./  Dosage: Adults: 1 tab.once dly.on empty stomach. Bedt.dos.may   improv.CNS sympt. tolerabil.
   organ dysfunct.incl.liv.inj., psych./GI disords., CNS effs., headache,   improv.CNS sympt. tolerabil.  Contraindications: Pregn. & lactat., mod-sev. ren.impairm., con-
   dizzin., hepatit., fatig., body fat redistribut./accumulat., periph./ fac.  Contraindications: Mod-sev.ren.impairm., pregn. & lactat., con-
   wasting, breast enlargem., elev.ser. lipid/ gluc.lev., osteonecros.esp.  com.astemizole/ cisapride/ midazolam/ triazolam or ergot derivat.,   com.astemizole/bepridil/ cisapride/midazolam/pimozide/triazolam
                                                              or ergot derivat., concom.voriconazole, safety & effic.in pts.less than
   in advanc.HIV &/longt.expos.to combin.ARV ther., immune reconsti-  safety & effic.in pts.less than 18 yrs.not est., sev.hepat. impairm.,
   tut. syndr., auto-immune disords.  concom.voriconazole, concom.meds/ combinat. contain efavirenz/  18 yrs.not est., safety & effic.not est. in hepatit. B vir.co-infects.,
                                                              concom.meds/ combinat. contain lamivudine, prev.liv.injury/-fail.
   Warnings and special precautions: Cross. placent. barrier in
   animals, excret.in breast milk, limit.data in elderly ≥ 65 yrs., do not   emtricitabine/ tenofovir/ lamivudine/adefovir dipivoxil.  hist.with efavirenz.
                                Side effects: Emtricitabine: Freq: Incr.cough, rhinit., naus., di-
                                                              Side effects: Lactic.acidos.& sev.hepatomegaly with steatos.incl.
   use with etravine without concom.atazanavir/ritonavir, darunavir/
   ritonavir or lopinavir/ritonavir combinat., avoid concom. oxcarbaz-  arrh., headache, asthen., rais. creatine kinase. Less freq: Depress.  fatal., sev.ac.exacerbat.of hepatit. B aft.discontinuat., ser.psych.
                                disord., dizzin., sleep disturbs., neurit., paraesthes., periph. neurop-
   epine/ phenytoin/ phenobarb./carbamazepine/St.John’s Wort, ad-  athy, abdom.pain, dyspeps., vomit, rash, urticar., vesiculobull./pus-  sympts. incl. sev.depress./suicid.ideat./delus.& pyschos.-like be-
                                                              hav., CNS sympts.incl.hallucinat./abnorm. think. & depersonalisat.
   min.2 hrs.bef./6 hrs.aft.antacids contain. polyval.cations, discont.  tular rash, allerg.reacts., skin discolourat., arthralg., myalg. Freq.
   ther./other suspect.agents immed. if any signs/sympt.of hypersens.  unknown: Neutropen., anaem., lactic acidos.usually accompan.   which gen.improv.with cont. ther., allerg.reacts., gynaecomast., GI
                                                              disturbs., body fat redistribut./accumulat., weight gain/-loss, ap-
   devel., monit. clinic.status incl.LFT & appropr.ther.init., CV risk as-
   sessm.in pts.with lipodystrophy evid., pt.to alert physic.if joint aches/   by sev.hepatomeg. & steatos., rais.liv. enzyme conc., hyperbilirubi-  petite incr., abnorm.co-ordinat., atax., convuls., hypoaesthes., par-
                                naem. Tenofovir: Freq: Asthen., N&V, diarrh. Less freq: Anorex.,
                                                              aesthes., periph. neuropathy, speech disord., tachycard., palpitat.,
   pain/stiffn./movem. diffic., opportunist. infects.& other complicat.
   of HIV infect.may contin., transmiss.risk through sex. cont./contam.  rais.ser. amylase conc., abdom.pain, flatul, hepatotox. Freq un-  tinnit., abnorm.vis., asthma, URTI, hepatit., hepat.fail., skin rash, incr.
                                                              swell., erythema multiforme, Stev.-John.syndr., alopec., skin exfoli-
                                known: Neutropen., haematur., allerg.reacts, lactic acidos.usually
   bld.not reduc., liv.funct.monit. recomm. in pts.with hepatit.B &/C co-
   infect., init./ maint. effect.hepatit.B ther.when start.dolutegravir in   accompan.by sev. hepatomegaly. & steatos., hypertriglyceridaem.,   at., urticar., nail disords., skin discolourat., acne, eczema, folliculos.,
                                hyperglycaem., hypophosphataem., depress., headache, dizzin., in-
   hepatit.B co-infect. pts., eval.any inflamm. sympt.& init.ther.if necess.  seborrh., photoallerg. dermatit., arthralg., myalg., myopathy, impot.,
   Drug interactions: Decr.plasma conc.with etravine, efavirenz, ri-  somn., periph.neuropathy, anx., chest pain, pneumon., dyspn., pan-  incr./decr.libido, fatig., asthen., hot flushes, malaise, influenza-like
                                creatit., dyspeps., rais.liv.enzymes & hepatit., skin rash., fev., sweat.,
   fampicin, tipranavir/ritonavir, fosamprenavir/ ritonavir, potent.decr.  sympts., pain, neutropen., anaem., hypertriglyceridaem., hypergly-
   conc.with nevirapine, decr.conc.with oxcarbazepine/ phenytoin/   weight loss, back pain, myalg., arthralg., rais.creatine kinase lev.,   caem., incr.cough, rhinit., dyspn., pancreatit., hyperpigmentat.of
   phenobarb./carbamazepine/St.John’s Wort, incr.metformin conc.,   nephrit., nephrogen. diabet.insipid., ren.impairm., ac.ren. fail., Fan-  palms &/soles, chest pain, pneumon., osteomalac., ren.impairm.
   incr.plasma conc.with atanavir/ ritonavir, incr.AUC & C max with   coni syndr., ac.tubular necros.  incl.ac.ren.fail., fev., sweat., lumb.spine/hip & both arms BMD decr.
                                                              from baseline, inflamm.respons.to indolent/resid. infects.necessit.
   atazanavir, potent. incr.dofetilide/pilsicainide plasma conc., decr.   Efavirenz: Freq: Dizzin., imp.concentrat., somnol., insomn., head-
   AUC & C max with antacids cont. polyval. cations/prod.cont.Ca/& Fe.  ache, N&V, diarrh., rash, prurit., incr. sweat., fatig., pain. Less freq:   furth.eval.& treatm.
                                                              Special precautions: Monit.hepat.funct.for sev. mnths.in pts.
                                Abnorm.dreams, anorex., hypoaesthes., dyspeps., abdom.pain. Freq
   TRELAVUE, GSK [P/S]          unknown: Weight gain/loss, abnorm.coordinat., atax., convuls., par-  co-infect.with HIV & HBV who discont. ther., obesity & prolong.nu-
   Dolutegravir sod. 50 mg, abacavir sulph. 600 mg, lamivudine 300 mg.  aesthes., neuropathy, trem., aggrav. depress., agitat., amnes., anx.,   cleoside use poss.risk fact.for lact.acidos., liv.dis.risk fact., discont.
   Indications: Treatm.of HIV infect.adults & adolesc. over 18 yrs.  apathy, incr. appet., confus., emot.lability, euphor., hallucinat., imp.  if find.suggest.lact.acidos./hepatotoxic., test for chron.hepatit.B
   who are ARV-treatm. naive/ HIV infect.without document./clinic.  co-ordinat., impot., decr./incr. libido, neuralg,, periph.neuropathy,   bef.init.ther., determ. creatin. clear.bef.init.ther., avoid with con-
   susp.resist.to any of the 3 ARV compon.  speech disord., vertigo, abnorm. vision, tinnit., taste pervers., flush.,   com./ rec. nephrotox.agents, immed.risk vs.benefit eval. of cont.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page316.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page312.html">312</a>&nbsp;&nbsp;&nbsp;<a href="page313.html">313</a>&nbsp;&nbsp;&nbsp;<a href="page314.html">314</a>&nbsp;&nbsp;&nbsp;<a href="page315.html">315</a>&nbsp;&nbsp;&nbsp;<a href="page316.html">316</a>&nbsp;&nbsp;&nbsp;<a href="page317.html">317</a>&nbsp;&nbsp;&nbsp;<a href="page318.html">318</a>&nbsp;&nbsp;&nbsp;<a href="page319.html">319</a>&nbsp;&nbsp;&nbsp;<a href="page320.html">320</a>&nbsp;&nbsp;&nbsp;<a href="page321.html">321</a>&nbsp;&nbsp;&nbsp;<a href="page322.html">322</a>
             </td>
             <td width="35%"><a href="page318.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page318.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
